CYFRA 21-1 in urine: a diagnostic marker for endometriosis?
- PMID: 25709504
- PMCID: PMC4332289
- DOI: 10.2147/IJWH.S75288
CYFRA 21-1 in urine: a diagnostic marker for endometriosis?
Abstract
Diagnostic workup of endometriosis usually involves laparoscopic inspection and histological examination of biopsies. Unequivocal laboratory parameters for this ailment have not been available in routine diagnostic evaluations thus far. In this study, we examined urine concentrations of cytokeratin 19 (CYFRA 21-1), a structural protein specific for epithelia. We performed immunoassays for CYFRA 21-1 in urine samples from women afflicted with endometriosis throughout their menstrual cycle. We observed a significant increase in CYFRA 21-1 concentrations, corrected by creatinine levels, in the late follicular phase as compared with the level in healthy controls. We conclude that cyclically increased CYFRA 21-1 concentrations in urine could serve as a valuable noninvasive diagnostic parameter in the workup of clinically manifesting endometriosis.
Keywords: CYFRA 21-1; biomarkers; immunoassay; menstrual cycle; noninvasive diagnosis.
Figures




Similar articles
-
Strengthening of CYFRA 21-1 using urine creatinine correction as potential endometriosis biomarker .F1000Res. 2025 May 14;13:46. doi: 10.12688/f1000research.135167.2. eCollection 2024. F1000Res. 2025. PMID: 40469991 Free PMC article.
-
Urine and serum concentrations of Cytokeratin 19 in preeclampsia.Eur J Obstet Gynecol Reprod Biol. 2014 Oct;181:311-5. doi: 10.1016/j.ejogrb.2014.08.020. Epub 2014 Aug 27. Eur J Obstet Gynecol Reprod Biol. 2014. PMID: 25203310
-
New electrochemiluminescent immunoassay for the determination of CYFRA 21-1: analytical evaluation and clinical diagnostic performance in urine samples of patients with bladder cancer.Clin Chem. 1999 Nov;45(11):1944-53. Clin Chem. 1999. PMID: 10545064 Clinical Trial.
-
Does the assessment of serum markers in patients with lung cancer aid in the clinical decision making process?Anticancer Res. 1996 Jul-Aug;16(4B):2161-8. Anticancer Res. 1996. PMID: 8694537 Review.
-
Biomarkers in endometriosis: challenges and opportunities.Fertil Steril. 2017 Mar;107(3):523-532. doi: 10.1016/j.fertnstert.2017.01.009. Epub 2017 Feb 8. Fertil Steril. 2017. PMID: 28189296 Review.
Cited by
-
Strengthening of CYFRA 21-1 using urine creatinine correction as potential endometriosis biomarker .F1000Res. 2025 May 14;13:46. doi: 10.12688/f1000research.135167.2. eCollection 2024. F1000Res. 2025. PMID: 40469991 Free PMC article.
-
Cancers Screening in an Asymptomatic Population by Using Multiple Tumour Markers.PLoS One. 2016 Jun 29;11(6):e0158285. doi: 10.1371/journal.pone.0158285. eCollection 2016. PLoS One. 2016. PMID: 27355357 Free PMC article.
-
Urinary biomarkers for the non-invasive diagnosis of endometriosis.Cochrane Database Syst Rev. 2015 Dec 23;2015(12):CD012019. doi: 10.1002/14651858.CD012019. Cochrane Database Syst Rev. 2015. PMID: 26695425 Free PMC article.
References
-
- ACOG Practice Bulletin. Management of endometriosis. Obstet Gynecol. 2010;116:223–236. [Number 114] - PubMed
-
- Ballweg ML. Impact of endometriosis on women’s health: comparative historical data show that the earlier the onset, the more severe the disease. Best Pract Res Clin Obstet Gynaecol. 2004;18(2):201–218. - PubMed
-
- Missmer SA, Hankinson SE, Spiegelman D, Barbieri RL, Marshall LM, Hunter DJ. Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am J Epidemiol. 2004;160:784–796. - PubMed
-
- Gao X, Outley J, Botteman M, Spalding J, Simon JA, Pashos CL. Economic burden of endometriosis. Fertil Steril. 2006;86(6):1561–1572. - PubMed
-
- Nassif J, Mattar S, Abu Musa A, Eid A. Endometriosis and cancer: what do we know? Minerva Ginecol. 2013;65(2):167–179. - PubMed
LinkOut - more resources
Full Text Sources